文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新兴的靶向转运体的纳米颗粒药物递送系统。

Emerging transporter-targeted nanoparticulate drug delivery systems.

作者信息

Su Hongyan, Wang Yan, Liu Shuo, Wang Yue, Liu Qian, Liu Guangxuan, Chen Qin

机构信息

Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.

出版信息

Acta Pharm Sin B. 2019 Jan;9(1):49-58. doi: 10.1016/j.apsb.2018.10.005. Epub 2018 Oct 24.


DOI:10.1016/j.apsb.2018.10.005
PMID:30766777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6361857/
Abstract

Transporter-targeted nanoparticulate drug delivery systems (nano-DDS) have emerged as promising nanoplatforms for efficient drug delivery. Recently, great progress in transporter-targeted strategies has been made, especially with the rapid developments in nanotherapeutics. In this review, we outline the recent advances in transporter-targeted nano-DDS. First, the emerging transporter-targeted nano-DDS developed to facilitate oral drug delivery are reviewed. These include improvements in the oral absorption of protein and peptide drugs, facilitating the intravenous-to-oral switch in cancer chemotherapy. Secondly, the recent advances in transporter-assisted brain-targeting nano-DDS are discussed, focusing on the specific transporter-based targeting strategies. Recent developments in transporter-mediated tumor-targeting drug delivery are also discussed. Finally, the possible transport mechanisms involved in transporter-mediated endocytosis are highlighted, with special attention to the latest findings of the interactions between membrane transporters and nano-DDS.

摘要

靶向转运体的纳米颗粒药物递送系统(纳米药物递送系统)已成为高效药物递送的有前景的纳米平台。最近,靶向转运体策略取得了巨大进展,尤其是随着纳米治疗学的快速发展。在本综述中,我们概述了靶向转运体的纳米药物递送系统的最新进展。首先,综述了为促进口服药物递送而开发的新兴靶向转运体纳米药物递送系统。这些包括改善蛋白质和肽类药物的口服吸收,促进癌症化疗中静脉给药向口服给药的转变。其次,讨论了转运体辅助脑靶向纳米药物递送系统的最新进展,重点是基于特定转运体的靶向策略。还讨论了转运体介导的肿瘤靶向药物递送的最新进展。最后,强调了转运体介导的内吞作用中可能涉及的转运机制,特别关注膜转运体与纳米药物递送系统之间相互作用的最新发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/759f2b5c7a9c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/6c8f0719693f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/ebf6a26e3029/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/c76c767e4b79/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/1c21cf476677/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/19911d4bb86f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/759f2b5c7a9c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/6c8f0719693f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/ebf6a26e3029/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/c76c767e4b79/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/1c21cf476677/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/19911d4bb86f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/6361857/759f2b5c7a9c/gr5.jpg

相似文献

[1]
Emerging transporter-targeted nanoparticulate drug delivery systems.

Acta Pharm Sin B. 2019-1

[2]
Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy.

J Control Release. 2017-8-26

[3]
Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy.

J Control Release. 2014-1-2

[4]
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability.

Asian J Pharm Sci. 2020-3

[5]
Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy.

Asian J Pharm Sci. 2020-3

[6]
Smart transformable nanomedicines for cancer therapy.

Biomaterials. 2021-4

[7]
Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials.

Pharmaceutics. 2022-4-15

[8]
Research and development of drug delivery systems based on drug transporter and nano-formulation.

Asian J Pharm Sci. 2020-3

[9]
The use of nanoparticulate delivery systems in metronomic chemotherapy.

Biomaterials. 2013-3-5

[10]
Recent Advances on Cellulose-Based Nano-Drug Delivery Systems: Design of Prodrugs and Nanoparticles.

Curr Med Chem. 2019

引用本文的文献

[1]
l-Type amino acid transporter 1-targeting nanoparticles for antisense oligonucleotide delivery to the CNS.

Mol Ther Nucleic Acids. 2024-9-16

[2]
Enteral Route Nanomedicine for Cancer Therapy.

Int J Nanomedicine. 2024

[3]
Nanogel: A versatile drug delivery system for the treatment of various diseases and their future perspective.

Drug Deliv Transl Res. 2025-2

[4]
A Patent Analysis on Nano Drug Delivery Systems.

Recent Pat Nanotechnol. 2025

[5]
Challenges in Optimizing Nanoplatforms Used for Local and Systemic Delivery in the Oral Cavity.

Pharmaceutics. 2024-5-7

[6]
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.

Int J Nanomedicine. 2024

[7]
Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review.

Molecules. 2023-12-20

[8]
Optimizing the enzymatic release of MMAE from DGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker.

Front Pharmacol. 2023-7-10

[9]
The feasibility of oral targeted drug delivery: Gut immune to particulates?

Acta Pharm Sin B. 2023-6

[10]
Intelligent nanotherapeutic strategies for the delivery of CRISPR system.

Acta Pharm Sin B. 2023-6

本文引用的文献

[1]
Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.

Drug Deliv. 2018-11

[2]
Biomimetic nanoparticles for inflammation targeting.

Acta Pharm Sin B. 2018-1

[3]
Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.

Acta Pharm Sin B. 2018-1

[4]
Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.

Eur J Pharm Biopharm. 2018-5-24

[5]
Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids.

Drug Deliv. 2018-11

[6]
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.

Nano Lett. 2018-5-9

[7]
Mesoporous silica nanoparticles for drug and gene delivery.

Acta Pharm Sin B. 2018-3

[8]
Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.

Curr Clin Pharmacol. 2018

[9]
Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective.

Cells. 2018-3-23

[10]
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.

Front Pharmacol. 2018-1-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索